ProLung named Med Tech Company of the Year 2019 by Global Health & Pharma – ProLung, Inc.
ProLung named Med Tech Company of the Year 2019 by Global Health & Pharma –...
Read More
ProLung Announces Preliminary Results from its PL-208 Clinical Trial and Next-Steps – ProLung, Inc.
In News
ProLung Announces Preliminary Results from its PL-208 Clinical Trial and Next-Steps – ProLung, Inc. Salt Lake...
Read More
ProLung named one of 50 Leading Companies of the Year 2018 by Silicon Review – ProLung, Inc.
ProLung named one of 50 Leading Companies of the Year 2018 by Silicon Review –...
Read More
ProLung Announces Voting Results from its 2018 Annual Meeting of Shareholders – ProLung, Inc.
In News
ProLung Announces Voting Results from its 2018 Annual Meeting of Shareholders – ProLung, Inc. SALT LAKE...
Read MoreProLung Announces Final Results from its PL-209 Repeatability Study – ProLung, Inc.
In News
ProLung Announces Final Results from its PL-209 Repeatability Study – ProLung, Inc. SALT LAKE CITY, UT...
Read MoreProLung Announces Preliminary Results of Consent Solicitation – ProLung, Inc.
In News
ProLung Announces Preliminary Results of Consent Solicitation – ProLung, Inc. - Consent Solicitation Clearly Failed to...
Read MoreProLung Announces an Intellectual Property and Regulatory Update – ProLung, Inc.
In News
ProLung Announces an Intellectual Property and Regulatory Update – ProLung, Inc. SALT LAKE CITY, UT /...
Read MoreFormer ProLung Directors Support The Company’s Interim CEO Jared Bauer And Incumbent Board Of Directors – ProLung, Inc.
In News
Former ProLung Directors Support The Company's Interim CEO Jared Bauer And Incumbent Board Of Directors...
Read MoreProLung Advises Shareholders to Disregard Former CEO’s Steven Eror’s Recent Illegal Press Release – ProLung, Inc.
In News
ProLung Advises Shareholders to Disregard Former CEO’s Steven Eror’s Recent Illegal Press Release – ProLung,...
Read More
ProLung, Inc. Announces Addition of Future Board Members – ProLung, Inc.
In News
Additions Bring Extensive Operating Experience in Medical Technology and Diagnostics as well as Repeated Success...
Read More
Letter to Shareholders (Sept 2018) from Jared Bauer, interim CEO – ProLung, Inc.
In News
Letter to Shareholders (Sept 2018) from Jared Bauer, interim CEO – ProLung, Inc. Dear ProLung Shareholders...
Read More
ProLung, Inc. Announces Organizational Changes to Sharpen Focus on Achieving FDA Approval and Successful Commercialization – ProLung, Inc.
In News
ProLung, Inc. Announces Organizational Changes to Sharpen Focus on Achieving FDA Approval and Successful Commercialization...
Read More